A Phase I/Ib Study of P1446A-05 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2014
Price : $35 *
At a glance
- Drugs Voruciclib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- Sponsors Piramal Enterprises
- 31 Aug 2018 Biomarkers information updated
- 02 Sep 2014 According to the ClinicalTrials.gov record, status changed from recruiting to suspended.
- 23 Jun 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.